OtherANALGESIA AND DRUGS OF ABUSE
Antinociceptive Effects of RB101, a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by a Cholecystokinin Type B Receptor Antagonist, as Revealed by Noxiously Evoked Spinal c-Fos Expression in Rats
Prisca Honoré, Jaroslava Buritova, Marie-Claude Fournié-Zaluski, Bernard P. Roques and Jean-Marie Besson
Journal of Pharmacology and Experimental Therapeutics April 1997, 281 (1) 208-217;
Prisca Honoré
Jaroslava Buritova
Marie-Claude Fournié-Zaluski
Bernard P. Roques
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 281, Issue 1
1 Apr 1997
OtherANALGESIA AND DRUGS OF ABUSE
Antinociceptive Effects of RB101, a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by a Cholecystokinin Type B Receptor Antagonist, as Revealed by Noxiously Evoked Spinal c-Fos Expression in Rats
Prisca Honoré, Jaroslava Buritova, Marie-Claude Fournié-Zaluski, Bernard P. Roques and Jean-Marie Besson
Journal of Pharmacology and Experimental Therapeutics April 1, 1997, 281 (1) 208-217;
OtherANALGESIA AND DRUGS OF ABUSE
Antinociceptive Effects of RB101, a Complete Inhibitor of Enkephalin-catabolizing Enzymes, Are Enhanced by a Cholecystokinin Type B Receptor Antagonist, as Revealed by Noxiously Evoked Spinal c-Fos Expression in Rats
Prisca Honoré, Jaroslava Buritova, Marie-Claude Fournié-Zaluski, Bernard P. Roques and Jean-Marie Besson
Journal of Pharmacology and Experimental Therapeutics April 1, 1997, 281 (1) 208-217;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement